Skip to main content
Fig. 2 | Trials

Fig. 2

From: Operationalising kangaroo Mother care before stabilisation amongst low birth Weight Neonates in Africa (OMWaNA): protocol for a randomised controlled trial to examine mortality impact in Uganda

Fig. 2

OMWaNA trial schedule of enrolment, interventions and assessments 1. The start of trial procedures (time 0) is defined as when the pulse oximeter is attached for cardio-respiratory monitoring 2. All participants are reviewed daily while admitted to the hospital 3. All participants receive continuous monitoring of heart rate (HR) and oxygen saturation (SpO2) for 72 h after randomisation. Continuous monitoring continues until participants no longer require any form of respiratory support 4. HR, SpO2, axillary temperature and respiratory rate are measured every 6 h until stability criteria are met, after which the frequency transitions to daily 5. Blood glucose is measured daily and may be discontinued once the participant tolerates full enteral feeds 6. Participants are weighed on day 5, then daily until discharge (unless deemed too unstable by site study staff) 7. Socioeconomic data, including household details, are collected within 48 h of enrolment. During this time, study staff also inform families that they will be asked about their household expenditures and activities over the coming month 8. For participants at Entebbe and Jinja Hospitals, cranial ultrasounds are performed on days 1, 3 and 7 of hospitalisation (or as an outpatient if discharged before day 7) and on follow-up at day 28–30 9. The Women’s Capabilities Index (WCI) is administered to all mothers within 48 h of enrolment and on days 28–30 to assess women’s wellbeing 10. The Maternal Infant Responsiveness Instrument (MIRI) is administered on days 28–30 to assess infant-caregiver attachment 11. Duration of admission is measured as the mean time (days and hours) from hospital admission to discharge

Back to article page